KC
IMGN

Kellner Capital’s Immunogen Inc IMGN Stock Holding History

Kellner Capital’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$2.05M Buy
+69,200
New +$1.38M 3.7% 11

Other funds holding IMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Kellner Capital's IMGN Position: Q4 2023 in Review

Kellner Capital opened a new position in Immunogen Inc (IMGN) in Q4 2023: 69,200 shares worth $2.05M. The stake represents 3.7% of the portfolio and ranks #11 among its holdings.

327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

  • Kellner Capital held 69,200 shares of Immunogen Inc worth $2.05M as of Q4 2023.
  • Immunogen Inc was a new Kellner Capital position in Q4 2023.
  • Immunogen Inc made up 3.7% of Kellner Capital's portfolio in Q4 2023, its #11 holding.
  • 327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on Kellner Capital's 13F filing for Q4 2023, filed 7 Feb 2024.